Inmune Bio Stock Probability of Future Stock Price Finishing Over 17.16
| INMB Stock | USD 4.67 0.02 0.43% |
INmune |
INmune Bio Target Price Odds to finish over 17.16
The tendency of INmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 17.16 or more in 90 days |
| 4.67 | 90 days | 17.16 | close to zero percent |
Based on a normal probability distribution, the odds of INmune Bio to move over $ 17.16 or more in 90 days from now is close to zero percent (This INmune Bio probability density function shows the probability of INmune Stock to fall within a particular range of prices over 90 days) . Probability of INmune Bio price to stay between its current price of $ 4.67 and $ 17.16 at the end of the 90-day period is about 85.96 .
Given the investment horizon of 90 days INmune Bio has a beta of -0.16. This usually indicates as returns on the benchmark increase, returns on holding INmune Bio are expected to decrease at a much lower rate. During a bear market, however, INmune Bio is likely to outperform the market. Additionally INmune Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. INmune Bio Price Density |
| Price |
Predictive Modules for INmune Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as INmune Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.INmune Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. INmune Bio is not an exception. The market had few large corrections towards the INmune Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold INmune Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of INmune Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | -0.16 | |
σ | Overall volatility | 0.51 | |
Ir | Information ratio | -0.02 |
INmune Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of INmune Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for INmune Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| INmune Bio generated a negative expected return over the last 90 days | |
| INmune Bio has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 155 K. Net Loss for the year was (30.01 M) with profit before overhead, payroll, taxes, and interest of 374 K. | |
| INmune Bio currently holds about 61.21 M in cash with (11.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.41. | |
| INmune Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 29.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Lowdell Mark William of 14423 shares of INmune Bio at 8.32 subject to Rule 16b-3 |
INmune Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of INmune Stock often depends not only on the future outlook of the current and potential INmune Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INmune Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18 M | |
| Cash And Short Term Investments | 35.8 M |
INmune Bio Technical Analysis
INmune Bio's future price can be derived by breaking down and analyzing its technical indicators over time. INmune Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of INmune Bio. In general, you should focus on analyzing INmune Stock price patterns and their correlations with different microeconomic environments and drivers.
INmune Bio Predictive Forecast Models
INmune Bio's time-series forecasting models is one of many INmune Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary INmune Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.